ArticleNature nanotechnology2026
All-optical modulation with single photons using an electron avalanche.
Article in Nature nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The distinctive characteristics of light, such as high-speed and low-loss propagation, low crosstalk and low power consumption, along with the unique quantum properties of photons, make it most suitable for various applications in communications, high-resolution imaging, optical computing and quantum information technologies. One limiting factor, however, is the weak optical nonlinearity of conventional media, which poses challenges for controlling light at ultralow intensities. Here we demonstrate all-optical modulation of the refractive index enabled by the electron avalanche process in silicon using a control beam with single-photon light intensities. The observed process corresponds to an extremely high nonlinear refractive index of
Identifiers
41249495What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.